Kellmeyer Terrie
Transaction: 05/04/2026
OTHER
Change
+50,000
Price
$8.58
Filing
05/14/2026
Type
OTHER
Anavex Life Sciences Corp.
AVXL • Biotechnology
$2.86
▲ +0.01 (+0.35%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$261.56M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 11.6Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 30, 2026, 12:06 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.86
Change0.35%
Shares Out91.45M
Market Cap$261.56M
Enterprise Value$143.23M
52W Range2.25 - 10.40
Beta1.14
P/E-20.14
P/B2.33
P/FCF-8.93
EV/EBITDA-11.01
EV/FCF-4.89
Price$2.86
Change0.35%
Shares Out91.45M
Market Cap$261.56M
Enterprise Value$143.23M
52W Range2.25 - 10.40
Beta1.14
P/E-20.14
P/B2.33
P/FCF-8.93
EV/EBITDA-11.01
EV/FCF-4.89
Earnings Yield-4.96%
FCF Yield-11.20%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio11.60
Quick Ratio11.60
Target$11.00
Target Upside284.62%
Target Median$11.00
Target Range11.00 - 11.00
Volume893.29K
Avg Volume1.10M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
37/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 11.6Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
92/100
Bullish
Bullish
11
Hold
2
Bearish
0
Price Target
2026-08-30
Low
$11.00
Mean
$11.00
Median
$11.00
High
$11.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Paeger Axel
Transaction: 02/23/2026
OTHER
Change
0
Price
Not reported
Filing
05/01/2026
Type
OTHER
Boenisch Sandra
Transaction: 01/06/2026
BUY
Change
+12,500
Price
$8.58
Filing
01/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kellmeyer Terrie | OTHER | +50,000 | $8.58 | 05/04/2026 | 05/14/2026 |
| Paeger Axel | OTHER | 0 | Not reported | 02/23/2026 | 05/01/2026 |
| Boenisch Sandra | BUY | +12,500 | $8.58 | 01/06/2026 | 01/09/2026 |
| MISSLING CHRISTOPHER U | BUY | +125,000 | $8.58 | 01/06/2026 | 01/09/2026 |
| MISSLING CHRISTOPHER U | BUY | +125,000 | $5.36 | 10/02/2025 | 10/03/2025 |
| Boenisch Sandra | BUY | +12,500 | $5.36 | 10/02/2025 | 10/03/2025 |
| MISSLING CHRISTOPHER U | SELL | -187,500 | $5.04 | 09/11/2025 | 09/12/2025 |
| MISSLING CHRISTOPHER U | SELL | -145,048 | $9.58 | 09/11/2025 | 09/12/2025 |
| MISSLING CHRISTOPHER U | BUY | +125,000 | $8.58 | 08/20/2025 | 08/22/2025 |
| Boenisch Sandra | BUY | +12,500 | $8.58 | 08/20/2025 | 08/22/2025 |
| Thomas Steffen | SELL | -50,000 | $1.76 | 06/05/2025 | 06/09/2025 |
| Thomas Steffen | SELL | -11,349 | $7.75 | 06/05/2025 | 06/09/2025 |
| MISSLING CHRISTOPHER U | BUY | +125,000 | $8.57 | 04/28/2025 | 04/30/2025 |
| Boenisch Sandra | BUY | +12,500 | $8.57 | 04/28/2025 | 04/30/2025 |
| Velden Claus Vander | BUY | +50,000 | $8.58 | 03/31/2025 | 04/02/2025 |
| Thomas Steffen | BUY | +50,000 | $8.58 | 03/31/2025 | 04/02/2025 |
| Skarpelos Athanasios | BUY | +50,000 | $8.58 | 03/31/2025 | 04/02/2025 |
| Ma Jiong | BUY | +50,000 | $8.58 | 03/31/2025 | 04/02/2025 |
| Donhauser Peter D.O. | BUY | +50,000 | $8.58 | 03/31/2025 | 04/02/2025 |
| MISSLING CHRISTOPHER U | SELL | -500,000 | $0.92 | 03/24/2025 | 03/26/2025 |